The Invoice Analysis and Reconciliation System is a real-time toolset that identifies, reports, and recovers contracted, GPO and/or 340B contract pricing discrepancies.
We understand that many factors influence pricing deviations. Our solution helps monitor and recover pricing discrepancies, helping to optimize compliance and savings for your 340B program.
Due to the size and complexity of contract portfolios, most subscribers do not have the resources to monitor each line item purchased. SUNRx can do this for you.
The SUNRx Invoice Analysis tool is unique in the 340B marketplace, and can recover between 1% and 7% of the total drug spend.
Since audits are performed within days of a purchase, subscribers recover the savings faster, at a fraction of the cost of aftermarket auditors.
Invoice Analysis is available to any provider type.
Learn more about our complete 340B solution. Ready for a change?